Showing results (1-10 of 873) with videos related to
Sort By:
Pageof 88
Current Diabetes Reports|April 29, 2010
Bile acid sequestrants for lipid and glucose controlBart Staels, Yehuda Handelsman, Vivian FonsecaDiabetes, Obesity & Metabolism|April 27, 2010
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidenceVivian A Fonseca, Yehuda Handelsman, Bart StaelsExpert Review of Clinical Pharmacology|December 7, 2011
Is combination therapy an effective way of reaching lipid goals in type 2 diabetes mellitus?Yehuda Handelsman, Vivian Fonseca, Julio RosenstockToxicologic Pathology|December 23, 2008
Metabolic syndrome pathophysiology and clinical presentationYehuda HandelsmanThe American Journal of Managed Care|December 20, 2024
Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic diseaseYehuda HandelsmanPediatric Endocrinology Reviews : PER|June 17, 2008
Treating diabetes with incretin hormones - clinical experienceYehuda HandelsmanAdvances in Therapy|August 25, 2019
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 DiabetesYehuda HandelsmanEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 2, 2015
POTENTIAL PLACE OF SGLT2 INHIBITORS IN TREATMENT PARADIGMS FOR TYPE 2 DIABETES MELLITUSYehuda HandelsmanPostgraduate Medicine|June 5, 2009
The role of colesevelam HCl in type 2 diabetes mellitus therapyYehuda HandelsmanMetabolic Syndrome and Related Disorders|December 15, 2010
The role of bile acid sequestrants in the management of type 2 diabetes mellitus: summary and future directionsYehuda HandelsmanPageof 88